INCIDENCE OF HEMATOLOGICAL MALIGNANCIES IN SICKLE CELL PATIENTS FROM AN INDIAN TERTIARY CARE TEACHING HOSPITAL

Sima Chauhan; Santosh Kumar Swain; Mahesh Chandra Sahu

doi:10.22159/ajpcr.2018.v11i3.22790

Authors

Sima Chauhan Department of Pathology, Institute of Medical Sciences and Sum Hospital, Siksha â€˜Oâ€™ Anusandhan University, Bhubaneswar â€“ 751 003, Odisha, India.
Santosh Kumar Swain Department of Otorhinolaryngology, Institute of Medical Sciences and Sum Hospital, Siksha â€˜Oâ€™ Anusandhan University, Bhubaneswar â€“ 751 003, Odisha, India.
Mahesh Chandra Sahu Directorate of Medical Research, Directorate of Medical Research, Institute of Medical Sciences and Sum Hospital, Siksha â€˜Oâ€™ Anusandhan University, Bhubaneswar â€“ 751 003, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i3.22790

Keywords:

False-positive, Hematological malignancies, Sickle cell disease, True-positive

Abstract

Â Objective: Sickle cell disease (SCD) involves multiple systems and is manifested by variable degree of anemia, acute vaso-occlusive episodes, and chronic organ damage. Small case series have hinted at increased incidence of cancer among SCD patients, but no examination of population-based data in Odisha has been reported. Here, we have reported the association of hematological malignancies and SCD in our region.

Methods: In this prospective study, we have documented all the demographic and clinical data of sickle cell patients during the past 3 years from June 2013 to May 2016. Simultaneously, the bone marrow (BM) aspiration and biopsy were carried out for all patients. This study was approved from the Institutional Ethics Committee.

Results: A total number of 267 sickle cell patients were screened for malignancy by both BM aspiration and biopsy. Among them, 6 cases of malignancies were detected by both BM aspiration and biopsy method.

Conclusion: Our study shows a association between SCD and hematological malignancies which could be due to treatment with hydroxyurea or accumulation of multiple genetic abnormalities due to a high degree of proliferative activity of marrow cells.

Downloads

Download data is not yet available.

References

Steensma DP, Gibbons RJ, Higgs DR. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood 2005;105:443-52.

Paydas S. Sickle cell anemia and hematological neoplasias. Leuk Lymphoma 2002;43:1431-4.

Goldin AG, Kelty KC, Beard MF. Sickle cell anemia terminating in acute myeloblastic leukemia. Ann Intern Med 1953;39:920-8.

Anderson IS, Yeung KY, Hillman D, Lessin LS. Multiple myeloma in a patient with sickle cell anemia. Interacting effects on blood viscosity. Am J Med 1975;59:568-74.

Nowell PC, Jensen J, Gardner F. Two complex translocations in chronic granulocytic leukemia involving chromosomes 22, 9, and a third chromosome. Humangenetik 1975;30:13-21.

Samal GC. Sickle cell anemia with acute myeloid leukemia--(a case report). Indian Pediatr 1979;16:453-4.

Salmassi S, Currie ET, Bolf EC, Hernandez M, Kasprisin DO. Management of hodgkinâ€™s disease in a patient with sickle cell anemia. Cancer 1981;48:252-4.

Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT 3rd, et al. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984;311:780-3.

Morabito F, Callea V, Brugiatelli M, Dâ€™Ascola D, Palazzolo A, Neri A, et al. Non-hodgkinâ€™s lymphoma associated with sickle cell disease: A case report. Tumori 1987;73:523-4.

Labi M, Haponik EF, Welsh RA, Summer WR. Alveolar cell carcinoma complicating sickle cell anemia: A chance occurrence? Am J Hematol 1989;32:222-5.

Tawfik OW, Moral LA, Richardson WP, Lee KR. Multicentric bilateral renal cell carcinomas and a vascular leiomyoma in a child. Pediatr Pathol 1993;13:289-98.

Shokunbi WA, Campbell OB, Ogunbiyi JO. Malignant haemangioendothelioma of bone in a HbSC disease patient-a case report. Afr J Med Med Sci 1996;25:293-6.

Stricker RB, Linker CA, Crowley TJ, Embury SH. Hematologic malignancy in sickle cell disease: Report of four cases and review of the literature. Am J Hematol 1986;21:223-30.

Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.

Baron BW, Mick R, Baron JM. Hematuria in sickle cell anemia-not always benign: Evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma. Acta Haematol 1994;92:119-22.

Dawkins FW, Kim KS, Squires RS, Chisholm R, Kark JA, Perlin E, et al. Cancer incidence rate and mortality rate in sickle cell disease patients at howard university hospital: 1986-1995. Am J Hematol 1997;55:188-92.

Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the united states. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995;75:2186-95.

Miller BA, Ries LA, Hankey BF, Clegg L, Edwards BK. SEER cancer statistics review: 1973-90. Bethesda, MD: National Cancer Institute, NIH Pub; 1993. p. 93-2789.

American Cancer Society. Cancer Facts and Figures for Minority Americans. Atlanta: American Cancer Society, Information pamphlet; 1991.

Schultz WH, Ware RE. Malignancy in patients with sickle cell disease. Am J Hematol 2003;74:249-53.

Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol 2010;85:403-8.

Dawkins FW, Kim KS, Squires RS, Chisholm R, Kark JA, Perlin E, et al. Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986-1995. Am J Hematol 1997;55:188-92.

Hasan SH, Elongovan S. Conventional and advances diagnostic aids in oral cancer screening-The journey so far. Int J Pharm Pharm Sci 2014;7:29-33.

Mehdinejad M, Khosravi AD, Morvaridi A. Study of prevalence and antimicrobial susceptibility pattern of bacteria isolated from blood cultures. J Biol Sci 2009;9:249-53.